143 Episoade

  1. Immunotherapy rechallenge in NSCLC

    Publicat: 03.03.2022

  2. ESO’s career development programme

    Publicat: 24.02.2022

  3. Summary/Review - Reporting Guidelines - CONSORT

    Publicat: 17.02.2022

  4. Summary/Review: Long-term results of SNB after NCT for primary cN1/2 breast who convert to cN0

    Publicat: 10.02.2022

  5. Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease.

    Publicat: 03.02.2022

  6. Intraoperative breast ultrasound

    Publicat: 27.01.2022

  7. Summary/Review - Reporting Guidelines - PRISMA 2020

    Publicat: 20.01.2022

  8. Summary/Review - The use of Artificial Intelligence in the Oncology field. Addressing all the hype and skepticism.

    Publicat: 13.01.2022

  9. Advanced Gastric Cancer

    Publicat: 09.12.2021

  10. PARP inhibitors for the treatment of ovarian cancer

    Publicat: 02.12.2021

  11. The role of clinician-scientists in modern oncology

    Publicat: 25.11.2021

  12. Pharmacologic interactions with new drugs

    Publicat: 18.11.2021

  13. Positive Resection Margins in Colon Cancer

    Publicat: 11.11.2021

  14. Immunotherapy in Lung Cancer

    Publicat: 04.11.2021

  15. Low HR positive breast cancer

    Publicat: 28.10.2021

  16. Possibilities of tackling side effects of cancer therapies

    Publicat: 21.10.2021

  17. Fertility preservation in young cancer patients

    Publicat: 14.10.2021

  18. CDK4/6i in HR+HER2- breast cancer

    Publicat: 07.10.2021

  19. Treatment selection in castration-resistant prostate cancer

    Publicat: 30.09.2021

  20. Questions and Controversies in Localized Head and Neck Cancer

    Publicat: 23.09.2021

6 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

Visit the podcast's native language site